Role of sympathetic nervous system and neuropeptides in obesity hypertension

被引:91
作者
Hall, JE [1 ]
Brands, MW [1 ]
Hildebrandt, DA [1 ]
Kuo, J [1 ]
Fitzgerald, S [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
关键词
obesity; leptin; angiotensin; kidney; sodium excretion;
D O I
10.1590/S0100-879X2000000600001
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity is the most common cause of human essential hypertension in most industrialized countries. Although the precise mechanisms of obesity hypertension are not fully understood, considerable evidence suggests that excess renal sodium reabsorption and a hypertensive shift of pressure natriuresis play a major role. Sympathetic activation appears to mediate at least part of the obesity-induced sodium retention and hypertension since adrenergic blockade or renal denervation markedly attenuates these changes. Recent observations suggest that leptin and its multiple interactions with neuropeptides in the hypothalamus may link excess weight gain with increased sympathetic activity. Leptin is produced mainly in adipocytes and is believed to regulate energy balance by acting on the hypothalamus to reduce food intake and to increase energy expenditure via sympathetic activation. Short-term administration of leptin into the cerebral ventricles increases renal sympathetic activity, and long-term leptin infusion at rates that mimic plasma concentrations found in obesity raises arterial pressure and heart rate via adrenergic activation in nonobese rodents, Transgenic mice overexpressing leptin also develop hypertension. Acute studies suggest that the renal sympathetic effects of leptin may depend on interactions with other neurochemical pathways in the hypothalamus, including the melanocortin-4 receptor (MC4-R). However, the role of this pathway in mediating the long-term effects of leptin on blood pressure is unclear. Also, it is uncertain whether there is resistance to the chronic renal sympathetic and blood pressure effects of leptin in obese subjects. In addition, leptin also has other cardiovascular and renal actions, such as stimulation of nitric oxide formation and improvement of insulin sensitivity, which may tend to reduce blood pressure in some conditions. Although the role of these mechanisms in human obesity has not been elucidated, this remains a fruitful area for further investigation, especially in view of the current "epidemic" of obesity in most industrialized countries.
引用
收藏
页码:605 / 618
页数:14
相关论文
共 60 条
[1]  
Alexander J, 1979, US DHEW PUBLICATION, V70-1631, P61
[2]   Hypertension in obese Zucker rats - Role of angiotensin II and adrenergic activity [J].
AlonsoGalicia, M ;
Brands, MW ;
Zappe, DH ;
Hall, JE .
HYPERTENSION, 1996, 28 (06) :1047-1054
[3]  
BERCHTOLD P, 1981, INT J OBESITY, V5, P1
[4]  
Carroll JF, 1998, FASEB J, V12, pA708
[5]   Obese hypertensive rabbits develop concentric and eccentric hypertrophy and diastolic filling abnormalities [J].
Carroll, JF ;
Braden, DS ;
Cockrell, K ;
Mizelle, HL .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (02) :230-233
[6]   HEMODYNAMIC-ALTERATIONS IN HYPERTENSIVE OBESE RABBITS [J].
CARROLL, JF ;
HUANG, M ;
HESTER, RL ;
COCKRELL, K ;
MIZELLE, HL .
HYPERTENSION, 1995, 26 (03) :465-470
[7]   Effects of central leptin administration on blood pressure in normotensive rats [J].
Casto, RM ;
VanNess, JM ;
Overton, JM .
NEUROSCIENCE LETTERS, 1998, 246 (01) :29-32
[8]   Role of melanocortinergic neurons in feeding and the agouti obesity syndrome [J].
Fan, W ;
Boston, BA ;
Kesterson, RA ;
Hruby, VJ ;
Cone, RD .
NATURE, 1997, 385 (6612) :165-168
[9]   Obesity and the hypothalamus: Novel peptides for new pathways [J].
Flier, JS ;
Maratos-Flier, E .
CELL, 1998, 92 (04) :437-440
[10]   INCIDENCE AND PRECURSORS OF HYPERTENSION IN YOUNG-ADULTS - THE FRAMINGHAM OFFSPRING STUDY [J].
GARRISON, RJ ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
PREVENTIVE MEDICINE, 1987, 16 (02) :235-251